136 related articles for article (PubMed ID: 23897585)
61. DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients.
Schotten LM; Darwiche K; Seweryn M; Yildiz V; Kneuertz PJ; Eberhardt WEE; Eisenmann S; Welter S; Sisson BE; Pietrzak M; Wiesweg M; Ploenes T; Hager T; He K; Freitag L; Aigner C; Taube C; Oezkan F
Eur J Cancer; 2021 Apr; 147():142-150. PubMed ID: 33662689
[TBL] [Abstract][Full Text] [Related]
62. Exploration of the platelet proteome in patients with early-stage cancer.
Sabrkhany S; Kuijpers MJE; Knol JC; Olde Damink SWM; Dingemans AC; Verheul HM; Piersma SR; Pham TV; Griffioen AW; Oude Egbrink MGA; Jimenez CR
J Proteomics; 2018 Apr; 177():65-74. PubMed ID: 29432918
[TBL] [Abstract][Full Text] [Related]
63. Multiple marker detection in peripheral blood for NSCLC diagnosis.
Ulivi P; Mercatali L; Casoni GL; Scarpi E; Bucchi L; Silvestrini R; Sanna S; Monteverde M; Amadori D; Poletti V; Zoli W
PLoS One; 2013; 8(2):e57401. PubMed ID: 23468981
[TBL] [Abstract][Full Text] [Related]
64. Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene.
Cao Y; Vo T; Millien G; Tagne JB; Kotton D; Mason RJ; Williams MC; Ramirez MI
J Biol Chem; 2010 Jan; 285(3):2152-64. PubMed ID: 19906647
[TBL] [Abstract][Full Text] [Related]
65. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
[TBL] [Abstract][Full Text] [Related]
66. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.
Wei J; Gao W; Zhu CJ; Liu YQ; Mei Z; Cheng T; Shu YQ
Chin J Cancer; 2011 Jun; 30(6):407-14. PubMed ID: 21627863
[TBL] [Abstract][Full Text] [Related]
67. Baseline serum β-carotene concentration and mortality among long-term asbestos-exposed insulators.
Hashim D; Gaughan D; Boffetta P; Lucchini RG
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):555-60. PubMed ID: 25542826
[TBL] [Abstract][Full Text] [Related]
68. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts.
Michaud DS; Feskanich D; Rimm EB; Colditz GA; Speizer FE; Willett WC; Giovannucci E
Am J Clin Nutr; 2000 Oct; 72(4):990-7. PubMed ID: 11010942
[TBL] [Abstract][Full Text] [Related]
69. Plasma proGRP concentration is sensitive and specific for discriminating small cell lung cancer from nonmalignant conditions or non-small cell lung cancer.
Kim HR; Oh IJ; Shin MG; Park JS; Choi HJ; Ban HJ; Kim KS; Kim YC; Shin JH; Ryang DW; Suh SP
J Korean Med Sci; 2011 May; 26(5):625-30. PubMed ID: 21532852
[TBL] [Abstract][Full Text] [Related]
70. Estrogen-induced upregulation of Sftpb requires transcriptional control of neuregulin receptor ErbB4 in mouse lung type II epithelial cells.
Zscheppang K; Konrad M; Zischka M; Huhn V; Dammann CE
Biochim Biophys Acta; 2011 Oct; 1813(10):1717-27. PubMed ID: 21777626
[TBL] [Abstract][Full Text] [Related]
71. Oxidant stress and B vitamins status in patients with non-small cell lung cancer.
Tsao SM; Yin MC; Liu WH
Nutr Cancer; 2007; 59(1):8-13. PubMed ID: 17927496
[TBL] [Abstract][Full Text] [Related]
72. Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.
Christen WG; Gaziano JM; Hennekens CH
Ann Epidemiol; 2000 Feb; 10(2):125-34. PubMed ID: 10691066
[TBL] [Abstract][Full Text] [Related]
73. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
[TBL] [Abstract][Full Text] [Related]
74. β-Carotene Supplementation and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: The Role of Tar and Nicotine.
Middha P; Weinstein SJ; Männistö S; Albanes D; Mondul AM
Nicotine Tob Res; 2019 Jul; 21(8):1045-1050. PubMed ID: 29889248
[TBL] [Abstract][Full Text] [Related]
75. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
76. Validation of a Blood-Based Protein Biomarker Panel for a Risk Assessment of Lethal Lung Cancer in the Physicians' Health Study.
Song L; Irajizad E; Rundle A; Sesso HD; Gaziano JM; Vykoukal JV; Do KA; Dennison JB; Ostrin EJ; Fahrmann JF; Perera F; Hanash S
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893188
[TBL] [Abstract][Full Text] [Related]
77. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.
Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Cherniack MG; Brodkin CA; Hammar S
J Natl Cancer Inst; 1996 Nov; 88(21):1550-9. PubMed ID: 8901853
[TBL] [Abstract][Full Text] [Related]
78. Pro-surfactant protein B as a biomarker for lung cancer prediction.
Sin DD; Tammemagi CM; Lam S; Barnett MJ; Duan X; Tam A; Auman H; Feng Z; Goodman GE; Hanash S; Taguchi A
J Clin Oncol; 2013 Dec; 31(36):4536-43. PubMed ID: 24248694
[TBL] [Abstract][Full Text] [Related]
79. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.
Wikoff WR; Hanash S; DeFelice B; Miyamoto S; Barnett M; Zhao Y; Goodman G; Feng Z; Gandara D; Fiehn O; Taguchi A
J Clin Oncol; 2015 Nov; 33(33):3880-6. PubMed ID: 26282655
[TBL] [Abstract][Full Text] [Related]
80. Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.
; Guida F; Sun N; Bantis LE; Muller DC; Li P; Taguchi A; Dhillon D; Kundnani DL; Patel NJ; Yan Q; Byrnes G; Moons KGM; Tjønneland A; Panico S; Agnoli C; Vineis P; Palli D; Bueno-de-Mesquita B; Peeters PH; Agudo A; Huerta JM; Dorronsoro M; Barranco MR; Ardanaz E; Travis RC; Byrne KS; Boeing H; Steffen A; Kaaks R; Hüsing A; Trichopoulou A; Lagiou P; La Vecchia C; Severi G; Boutron-Ruault MC; Sandanger TM; Weiderpass E; Nøst TH; Tsilidis K; Riboli E; Grankvist K; Johansson M; Goodman GE; Feng Z; Brennan P; Johansson M; Hanash SM
JAMA Oncol; 2018 Oct; 4(10):e182078. PubMed ID: 30003238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
